Mesoblast (MESO) Depreciation & Amortization (CF) (2016 - 2023)

Mesoblast (MESO) posted Depreciation & Amortization (CF) of $990000.0 for Q1 2023, down 8.76% sequentially from $1.1 million in Q4 2022, and down 11.13% YoY from $1.1 million in Q1 2022.

Mesoblast (MESO) Depreciation & Amortization (CF) (2016 - 2023) Analysis & Trends

Mesoblast has reported Depreciation & Amortization (CF) for 8 years, with the latest figure at $990000.0 in Q1 2023.

  • Quarterly Depreciation & Amortization (CF) fell 11.13% year-over-year to $990000.0 in Q1 2023, while the trailing twelve-month figure through Jun 2024 was $990000.0 (down 68.87% YoY) and the FY2017 annual result came in at $3.1 million, up 239.46% from the prior year.
  • Depreciation & Amortization (CF) slipped to $990000.0 in Q1 2023 per MESO's latest filing, from $1.1 million in the prior quarter.
  • Over five years, Depreciation & Amortization (CF) peaked at $1.1 million in Q1 2022 and troughed at $849000.0 in Q3 2019.
  • A 5-year average of $1.0 million and a median of $1.1 million in 2021 frame the typical range for Depreciation & Amortization (CF).
  • The sharpest annual moves came in 2019 and 2023: Depreciation & Amortization (CF) jumped 53.25% in 2019, then decreased 11.13% in 2023.
  • Over 5 years, Depreciation & Amortization (CF) stood at $849000.0 in 2019, then increased by 18.37% to $1.0 million in 2020, then advanced by 9.65% to $1.1 million in 2021, then decreased by 1.54% to $1.1 million in 2022, then slipped by 8.76% to $990000.0 in 2023.
  • According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $990000.0, $1.1 million, and $1.1 million for Q1 2023, Q4 2022, and Q3 2022 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 56.50 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 123.70 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - 2.10 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 40.52 Mn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 3.18 Mn
10 Mesoblast 2.01 Bn 1.87 Bn - -

Historic Data

Download Data
DateValue
Mar 31, 2023 990,000.00
Mar 31, 2023 990,000.00
Dec 31, 2022 1.09 Mn
Dec 31, 2022 1.09 Mn
Sep 30, 2022 1.11 Mn
Sep 30, 2022 1.11 Mn
Mar 31, 2022 1.11 Mn
Mar 31, 2022 1.11 Mn
Dec 31, 2021 1.10 Mn
Dec 31, 2021 1.10 Mn
Sep 30, 2021 1.09 Mn
Sep 30, 2021 1.09 Mn
Sep 30, 2020 1.01 Mn
Sep 30, 2020 1.01 Mn
Sep 30, 2019 849,000.00
Sep 30, 2019 849,000.00
Sep 30, 2018 554,000.00
Sep 30, 2018 554,000.00
Mar 31, 2018 832,000.00
Mar 31, 2018 832,000.00